We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Tests Diabetes Drug as COVID-19 Treatment in Phase 3 Trial
AstraZeneca Tests Diabetes Drug as COVID-19 Treatment in Phase 3 Trial
AstraZeneca has begun a phase 3 clinical trial to evaluate its diabetes drug Farxiga (dapagliflozin) as a possible treatment for hospitalized COVID-19 patients.